Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D009316:National Institutes of Health (U.S.); D014481:United States
D000970:Antineoplastic Agents